Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CDw17 Antibody (HO18.3G-6.F5), Novus Biologicals™
SDP

Mouse Monoclonal Antibody

$243.50 - $487.50

Specifications

Antigen CDw17
Clone HO18.3G-6.F5
Concentration 0.2 mg/mL
Dilution Flow Cytometry 0.5 - 1 ug/million cells in 0.1 ml, Immunofluorescence 0.5 - 1.0 ug/ml
Applications Flow Cytometry, Immunofluorescence
View More Specs

Products 3
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
NBP24527900
SDP
View Documents
Novus Biologicals
NBP2452790.02MG
0.02 mg
Each for $243.50
Only null left
Add to Cart
 
NBP24527901
SDP
View Documents
Novus Biologicals
NBP2452790.1MG
0.1 mg
Each for $487.50
Only null left
Add to Cart
 
NBP24527902
SDP
View Documents
Novus Biologicals
NBP2452790.2MG
0.2 mg N/A N/A N/A
Description

Description

Ensure accurate, reproducible results in Flow Cytometry, Immunofluorescence

CDw17 Monoclonal specifically detects CDw17 in Human samples. It is validated for Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunofluorescence.
Specifications

Specifications

CDw17
0.2 mg/mL
Flow Cytometry, Immunofluorescence
Unconjugated
Mouse
Human
8869
B-2 Microglobulin associated proteins from a detergent lysate of human PBL
Primary
Store at 4C.
HO18.3G-6.F5
Flow Cytometry 0.5 - 1 ug/million cells in 0.1 ml, Immunofluorescence 0.5 - 1.0 ug/ml
Monoclonal
Purified
RUO
10mM PBS and 0.05% BSA with 0.05% Sodium Azide
ST3GAL5
IgM
Protein A or G purified
CD17 is an intermediate glycosphingolipid from the metabolism of higher gangliosides that localizes to sphingolipid-sterol rafts. CD17 is detectable in monocytes, granulocytes, basophils, platelets, a subset of peripheral B cells (CD19+) and tonsil dendritic cells. It is rapidly down regulated on activated granulocytes and is upregulated on IL-2 activated T lymphocytes. CD17 binds to bacteria and may function in phagocytosis. VEGF-treated endothelial cells can produce CD17, which can then mediate signaling toward PECAM-1 expression and angiogenesis. Tumor necrosis factor alpha (TNFalpha)-induced astrogliosis (astrocyte proliferation and glial fibrillary acidic protein (GFAP) upregulation) in response to neuro-inflammation (i.e. spinal cord injury) causes an increase in intracellular levels of CD17. Aberrant levels of glycosphingolipids are a feature of cancer cells and may influence integrin clustering and internalization.
Videos
SDS
Documents

Documents

Product Certifications

For Research Use Only

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.